0 followers
Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.
Kleanthis G. Xanthopoulos
Artiva Biotherapeutics
1 follower
Elicio Therapeutics
1 follower
EF Education First
13 followers
Cytokinetics
11 followers
Jnana Therapeutics
1 follower
brightwheel
10 followers
Sonoma Biotherapeutics
1 follower
Primer
1 follower
Neurocrine Biosciences
5 followers
Coherus BioSciences
5 followers
4D Molecular Therapeutics
3 followers
Explore companies